ID21413A - Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on - Google Patents

Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on

Info

Publication number: ID21413A
Authority: ID; Indonesia
Prior art keywords: turunan; dekan; triaza; spiro
Prior art date: 1997-12-05

Application number

IDP981576A

Other languages

English (en)

Inventor

Geo Adam

Andrea Cesura

Guido Galley

Francois Jenck

Stephan Roever

Juergen Wichmann

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-05

Filing date

1998-12-03

Publication date

1999-06-10

1998-12-03 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1999-06-10 Publication of ID21413A publication Critical patent/ID21413A/id

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Addiction (AREA)
Child & Adolescent Psychology (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
Color Printing (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

IDP981576A 1997-12-05 1998-12-03 Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on ID21413A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP97121427		1997-12-05

Publications (1)

Publication Number	Publication Date
ID21413A true ID21413A (id)	1999-06-10

Family

ID=8227753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDP981576A ID21413A (id)	1997-12-05	1998-12-03	Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on

Country Status (29)

Country	Link
US (1)	US6043366A (id)
JP (1)	JP3366868B2 (id)
KR (1)	KR19990062800A (id)
CN (1)	CN1118467C (id)
AR (1)	AR016428A1 (id)
AT (1)	ATE212635T1 (id)
AU (1)	AU744338B2 (id)
BR (1)	BR9805297B1 (id)
CA (1)	CA2255171C (id)
CO (1)	CO4990965A1 (id)
CZ (1)	CZ399698A3 (id)
DE (1)	DE69803653T2 (id)
DK (1)	DK0921125T3 (id)
ES (1)	ES2170446T3 (id)
HR (1)	HRP980613A2 (id)
HU (1)	HUP9802807A3 (id)
ID (1)	ID21413A (id)
IL (1)	IL127399A0 (id)
MA (1)	MA26573A1 (id)
NO (1)	NO312161B1 (id)
NZ (1)	NZ333159A (id)
PE (1)	PE135299A1 (id)
PL (1)	PL330062A1 (id)
PT (1)	PT921125E (id)
SG (1)	SG71173A1 (id)
TR (1)	TR199802520A2 (id)
TW (1)	TW408123B (id)
YU (1)	YU55198A (id)
ZA (1)	ZA9811128B (id)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0997464B1 (en) *	1998-10-23	2005-02-16	Pfizer Inc.	1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists
US6686370B2 (en) *	1999-12-06	2004-02-03	Euro-Celtique S.A.	Triazospiro compounds having nociceptin receptor affinity
EP1420020B1 (en) *	2001-07-23	2008-05-28	Banyu Pharmaceutical Co., Ltd.	4-oxoimidazolidine-2-spiropiperidine derivative
PT1491212E (pt)	2002-03-29	2012-11-16	Mitsubishi Tanabe Pharma Corp	Medicamento para distúrbios de sono
AU2003268512A1 (en) *	2002-09-09	2004-03-29	Janssen Pharmaceutica N.V.	Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
WO2004058727A1 (en) *	2002-12-20	2004-07-15	Bayer Pharmaceuticals Corporation	Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
AU2004241134A1 (en) *	2003-05-23	2004-12-02	Zealand Pharma A/S	Triaza-spiro compounds as nociceptin analogues and uses thereof
ES2297502T3 (es) *	2003-10-23	2008-05-01	F. Hoffmann-La Roche Ag	Derivados de triaza-espiropiperidinas para uso como inhibidores de glyt-1 en el tratamiento de trastornos neurologicos y neuropsiquiatricos.
US20060178390A1 (en) *	2004-08-02	2006-08-10	Alfonzo Jordan	1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
KR20070113305A (ko) *	2005-03-22	2007-11-28	에프. 호프만-라 로슈 아게	Ｄｐｐ-ｉｖ 저해제의 신규 염 및 동질이상체
EP2035420A2 (en) *	2006-06-20	2009-03-18	Wyeth a Corporation of the State of Delaware	Kv1.5 potassium channel inhibitors
CN101622254B (zh) *	2006-11-28	2013-05-29	詹森药业有限公司	3-(3-氨基-2-(r)-羟基-丙基)-1-(4-氟-苯基)-8-(8-甲基-萘-1-基甲基)-1,3,8-三氮杂-螺[4.5]癸烷-4-酮的盐
MX2009009355A (es) *	2007-03-01	2009-09-11	Mitsubishi Tanabe Pharma Corp	Compuesto de bencimidazol y uso farmaceutico del mismo.
MX2009011006A (es) *	2007-04-09	2009-11-02	Janssen Pharmaceutica Nv	Derivados de 1,3,8-trisustituido-1,3,8-triaza-espiro[4.5]decano-4- ona como ligandos del receptor de orl-1 para el tratamiento de ansiedad y depresion.
PA8801401A1 (es) *	2007-10-25	2009-05-15	Janssen Pharmaceutica Nv	Arilindenopirimidinas y su uso como adenosina a2a
TW201016675A (en) *	2008-09-16	2010-05-01	Mitsubishi Tanabe Pharma Corp	Crystalline benzoimidazole compound and salt thereof
US20100076003A1 (en) *	2008-09-19	2010-03-25	Kathleen Battista	5-oxazolidin-2-one substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful as orl-1 receptor modulators
WO2010037081A1 (en) *	2008-09-29	2010-04-01	Palatin Technologies, Inc.	Melanocortin receptor-specific spiro-piperidine compounds
CA2765415A1 (en)	2009-06-16	2010-12-23	Merck Sharp & Dohme Corp.	Substituted -1,3,8-triazaspiro[4.5]decane-2,4-diones
CN107849044B (zh) *	2015-07-03	2021-06-25	豪夫迈·罗氏有限公司	作为ddr1抑制剂的三氮杂-螺癸酮类化合物
WO2023198181A1 (en) *	2022-04-15	2023-10-19	The Chinese University Of Hong Kong	Carbobicyclic nucleosides for treatment of viral infection

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3161644A (en) *	1962-06-22	1964-12-15	Res Lab Dr C Janssen N V	1-benzyl-4-substituted piperidines
US3155669A (en) *	1962-06-22	1964-11-03	Res Lab Dr C Janssen N V	2, 4, 8-triaza-spiro (4, 5) dec-2-enes
US3155670A (en) *	1962-06-22	1964-11-03	Res Lab Dr C Janssen N V	1-oxo-2, 4, 8, triaza-spiro (4, 5) decanes
US3238216A (en) *	1963-06-20	1966-03-01	Res Lab Dr C Janssen N V	Substituted 1, 3, 8-triaza-spiro (4, 5) decanes
JPS5212171A (en) *	1975-07-17	1977-01-29	Yoshitomi Pharmaceut Ind Ltd	Process for preparation of cyclohexane derivatives
GB1486546A (en) *	1975-02-28	1977-09-21	Yoshitomo Pharma Ind Ltd	4,4-diphenyl-cyclohexylpiperidine compounds and analogues thereof
JPS51100084A (id) *	1975-02-28	1976-09-03	Yoshitomi Pharmaceutical
JPS5934713B2 (ja) *	1976-01-05	1984-08-24	ウェルファイド株式会社	脂環式誘導体
US4076821A (en) *	1976-02-27	1978-02-28	Yoshitomi Pharmaceutical Industries, Ltd.	4,4-Diphenylcycloalkylpiperidines and psychotropic compositions thereof
MA19091A1 (fr) *	1980-03-10	1981-10-01	Janssen Pharmaceutica Nv	Nouveaux derives de i-(4-aryl-cyclohexyl)piperidine .
US4329353A (en) *	1980-10-22	1982-05-11	Janssen Pharmaceutica, N.V.	1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof
GR73633B (id) *	1980-03-10	1984-03-26	Janssen Pharmaceutica Nv
ATE67769T1 (de) *	1983-01-25	1991-10-15	Ciba Geigy Ag	Neue peptidderivate.
JPS6012357B2 (ja) *	1984-01-23	1985-04-01	吉富製薬株式会社	脂環式誘導体
CA2226058C (en) *	1997-01-30	2008-01-29	F. Hoffmann-La Roche Ag	8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives

1998
- 1998-11-27 PT PT98122511T patent/PT921125E/pt unknown
- 1998-11-27 AT AT98122511T patent/ATE212635T1/de active
- 1998-11-27 ES ES98122511T patent/ES2170446T3/es not_active Expired - Lifetime
- 1998-11-27 DK DK98122511T patent/DK0921125T3/da active
- 1998-11-27 DE DE69803653T patent/DE69803653T2/de not_active Expired - Lifetime
- 1998-12-03 US US09/204,184 patent/US6043366A/en not_active Expired - Fee Related
- 1998-12-03 AR ARP980106141A patent/AR016428A1/es active IP Right Grant
- 1998-12-03 ID IDP981576A patent/ID21413A/id unknown
- 1998-12-03 PE PE1998001176A patent/PE135299A1/es not_active Application Discontinuation
- 1998-12-03 PL PL98330062A patent/PL330062A1/xx unknown
- 1998-12-03 YU YU55198A patent/YU55198A/sh unknown
- 1998-12-03 SG SG1998005141A patent/SG71173A1/en unknown
- 1998-12-03 CA CA002255171A patent/CA2255171C/en not_active Expired - Fee Related
- 1998-12-03 NZ NZ333159A patent/NZ333159A/en unknown
- 1998-12-04 CZ CZ983996A patent/CZ399698A3/cs unknown
- 1998-12-04 KR KR1019980053080A patent/KR19990062800A/ko not_active Ceased
- 1998-12-04 JP JP34527898A patent/JP3366868B2/ja not_active Expired - Fee Related
- 1998-12-04 CN CN98122759A patent/CN1118467C/zh not_active Expired - Fee Related
- 1998-12-04 HU HU9802807A patent/HUP9802807A3/hu unknown
- 1998-12-04 TW TW087120132A patent/TW408123B/zh not_active IP Right Cessation
- 1998-12-04 NO NO19985684A patent/NO312161B1/no not_active IP Right Cessation
- 1998-12-04 CO CO98072457A patent/CO4990965A1/es unknown
- 1998-12-04 ZA ZA9811128A patent/ZA9811128B/xx unknown
- 1998-12-04 IL IL12739998A patent/IL127399A0/xx unknown
- 1998-12-04 HR HR97121427.5A patent/HRP980613A2/hr not_active Application Discontinuation
- 1998-12-04 BR BRPI9805297-7A patent/BR9805297B1/pt not_active IP Right Cessation
- 1998-12-04 AU AU96087/98A patent/AU744338B2/en not_active Ceased
- 1998-12-04 TR TR1998/02520A patent/TR199802520A2/xx unknown
- 1998-12-04 MA MA25369A patent/MA26573A1/fr unknown

Also Published As

Publication number	Publication date
NZ333159A (en)	2000-06-23
CZ399698A3 (cs)	1999-06-16
BR9805297A (pt)	2000-02-01
CA2255171C (en)	2009-09-29
PE135299A1 (es)	2000-01-18
PT921125E (pt)	2002-06-28
AR016428A1 (es)	2001-07-04
PL330062A1 (en)	1999-06-07
NO312161B1 (no)	2002-04-02
HUP9802807A2 (hu)	1999-08-30
SG71173A1 (en)	2000-03-21
NO985684D0 (no)	1998-12-04
DK0921125T3 (da)	2002-05-13
AU744338B2 (en)	2002-02-21
JPH11228575A (ja)	1999-08-24
ZA9811128B (en)	1999-06-07
KR19990062800A (ko)	1999-07-26
AU9608798A (en)	1999-06-24
JP3366868B2 (ja)	2003-01-14
TW408123B (en)	2000-10-11
DE69803653D1 (de)	2002-03-14
TR199802520A3 (tr)	1999-06-21
CN1118467C (zh)	2003-08-20
CO4990965A1 (es)	2000-12-26
CA2255171A1 (en)	1999-06-05
US6043366A (en)	2000-03-28
HU9802807D0 (en)	1999-02-01
HRP980613A2 (en)	1999-08-31
BR9805297B1 (pt)	2010-07-13
CN1222521A (zh)	1999-07-14
IL127399A0 (en)	1999-10-28
YU55198A (sh)	2001-12-26
ES2170446T3 (es)	2002-08-01
ATE212635T1 (de)	2002-02-15
DE69803653T2 (de)	2002-08-29
HUP9802807A3 (en)	2000-01-28
NO985684L (no)	1999-06-07
MA26573A1 (fr)	2004-12-20
TR199802520A2 (xx)	1999-06-21

Publication	Publication Date	Title
NO2006016I1 (no)	2006-11-27	7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt)	2005-01-31	4,5-diaril-imidazoles 2-substituidos
ID29241A (id)	2001-08-16	Turunan-turunan kinolin teranelasi-1,2
DK0891978T3 (da)	2002-07-01	5H-Thiazol(3,2-a)pyrimidinderivativer
ID24583A (id)	2000-07-27	Turunan-turunan 1,2,3,4-tetrahidronaftalena tersubstitusi
ID19773A (id)	1998-07-30	Turunan-turunan 1,3,8-triaza-spiro (4,5) dekan-4-ona tersubtitusi-8
BR9506532A (pt)	1997-09-16	1,2,3,4,-Tetraidro-5-Nitro-Pirimidinas substituidas
TR199802520A3 (tr)	1999-06-21	1,3,8-Triaza-spiro(4,5) dekan -4-on türevleri.
TR199800988A3 (tr)	1998-12-21	5' Deoksi-Sitidin türevleri.
BR9609884A (pt)	1999-03-23	N-aril- 1,2,4-triazolin-5-onas
ID26909A (id)	2001-02-15	Turunan-turunan 1,3,4-oksadiazolon
DK1149106T3 (da)	2003-07-14	4,5-azolo-oxindoler
MA24551A1 (fr)	1998-12-31	W.c.
DK1068200T3 (da)	2005-06-20	2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id)	2000-07-06	Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
ID26368A (id)	2000-12-14	Turunan-turunan 2 deoksi higromisin
ID20352A (id)	1998-12-03	Bahan herbisida 3,5-difluoropiridin
ES1036909Y (es)	1998-05-01	Pupitre infantil.
BR9508248A (pt)	1997-11-04	1,2,4,6-Tiatriazinas herbicidas
DK0966464T3 (da)	2003-09-22	Substituerede 2,4-diaminopyrimidiner
ES1037395Y (es)	1998-07-01	Tendedero antilluvia.
ES1038172Y (es)	1998-12-01	"caja-contenedor".
ID19473A (id)	1998-07-16	24-homo-26,27-heksafluoro-kolkalsiferol
FI971438A0 (fi)	1997-04-07	Koppling laemplig foer spaennings- eller spaenningsfri arbete, saerskilt koppling foer ljusbaogs- eller oeverstoemsskydd
FI971391A0 (fi)	1997-04-04	Koppling laemplig foer spaenningsarbete, saerskilt koppling foer ljusbaogs- eller oeverstoemsskydd